Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug
Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug
Acumen Pharmaceuticals在其用于阿尔茨海默病筛查药物Sabirnetug的临床试验第2阶段展示出令人鼓舞的结果
Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug
Acumen Pharmaceuticals在其用于阿尔茨海默病筛查药物Sabirnetug的临床试验第2阶段展示出令人鼓舞的结果
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间